Home Newsfeeds Scotiabank Initiates Coverage On SolarEdge Technologies with Sector Perform Rating, Announces Price Target of $345

Scotiabank Initiates Coverage On SolarEdge Technologies with Sector Perform Rating, Announces Price Target of $345

Scotiabank analyst Tristan Richardson initiates coverage on SolarEdge Technologies (NASDAQ:SEDG) with a Sector Perform rating and announces Price Target of $345.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Scotiabank analyst Tristan Richardson initiates coverage on SolarEdge Technologies (NASDAQ:SEDG) with a Sector Perform rating and announces Price Target of $345.

‘Really Happy With My Tesla:’ Italian Rally Driver Clocks Over 236K Miles On Model S Over 6 Years With Nearly Zero Maintenance

By Anan Ashraf

December 27, 7:00 AM

"Honestly not sure what the future will be... And I don't want to get into any electric car debates," Longhi wrote.

HTZ

FDA
News

Silverback Therapeutics Announced FDA’s Acceptance of ARS Pharmaceuticals’ NDA for Neffy (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) Including Anaphylaxis

By Charles Gross

October 21, 7:32 AM

Silverback Therapeutics, Inc. (Nasdaq: SBTX) ("Silverback") today announced that the U.S.

SBTX

Analyst Ratings

Where Tradeweb Markets Stands With Analysts

By Benzinga Insights

August 12, 11:11 AM

Over the past 3 months, 7 analysts have published their opinion on Tradeweb Markets (NASDAQ:TW) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Biden’s CHIPS Act Draws Momentum; IBM Earmarks $20B In Hudson Valley Region Over The Decade

By Anusuya Lahiri

October 6, 10:59 AM

Today U.S. President Joseph R. Biden, Jr. and International Business Machines Corp (NYSE:IBM) Chair and CEO Arvind Krishna will tour…

IBM

Scotiabank Initiates Coverage On SolarEdge Technologies with Sector Perform Rating, Announces Price Target of $345

Related Posts

‘Really Happy With My Tesla:’ Italian Rally Driver Clocks Over 236K Miles On Model S Over 6 Years With Nearly Zero Maintenance

Silverback Therapeutics Announced FDA’s Acceptance of ARS Pharmaceuticals’ NDA for Neffy (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) Including Anaphylaxis

Where Tradeweb Markets Stands With Analysts

Biden’s CHIPS Act Draws Momentum; IBM Earmarks $20B In Hudson Valley Region Over The Decade